期刊文献+

低温体外循环对顺式阿曲库胺和罗库溴胺用药量的影响 被引量:1

Effect of hypothermia on requirements of cisatracurium or rocuronium in patients undergoing cardiopulmonary bypass
原文传递
导出
摘要 目的观察低温心肺转流(CPB)对顺式阿曲库胺和罗库溴胺用药量的影响。方法择期心脏瓣膜置换手术32例随机分为顺式阿曲库铵(C组)和罗库溴铵(R组)两组,每组16例。全程肌松监测。全凭静脉麻醉。C组以0.1mg/kg顺式阿曲库铵,R组以0.6mg/kg罗库溴铵静脉推注插管,然后持续泵注,适时调整输注速率,维持T1/T0为15%。常规实施CPB,维持血温32℃,记录并计算两组肌松药平均输注速率。结果C组顺式阿曲库胺CPB中平均输注速率显著低于CPB前[(0.73±0.24)μg.kg-1.min-1vs.(1.11±0.25)μg.kg-1.min-1](P<0.05);R组罗库溴铵CPB前、中的输注速率相仿[(3.99±0.90)μg.kg-1.min-1vs.(4.31±0.71)μg.kg-1.min-1](P>0.05)。结论32℃低温行CPB时,维持相同肌松水平的顺式阿曲库胺需求量明显减少;但罗库溴铵用量未受到低温的明显影响。 Objective To investigate the influence of mild hypothermic cardiopulmonary bypass(CPB)on the requirements of cisatracurium or rocuronium.Methods Sixty-two patients scheduled for selective mitral valve replacement were divided into two groups with 16 cases each.Cisatracurium 0.1mg/kg(group C)or rocuronium 0.6mg/kg(group R)was injected for intubation,which was followed by infution to keep T1/T0 at 15% during operation.The mean infusion rates before,during and after CPB were calculated.Results The cisatracurium infusion rate was higher during CPB than that before[(0.73±0.24)μg·kg-1·min-1 vs.(1.11±0.25)μg·kg-1·min-1](P0.05).The rocuronium infusion rate during CPB was similar to that before[(3.99±0.90)μg·kg-1·min-1 vs.(4.31±0.71)μg·kg-1· min-1](P0.05).Conclusion To keep a same level of neuromuscular blockade,the requirement of cisatracurium is remarkably less during CPB with 32℃ hypothermia than that before CPB,which is not when rocuronium is used instead of cisatracurium.
出处 《江苏医药》 CAS CSCD 北大核心 2010年第8期904-905,共2页 Jiangsu Medical Journal
关键词 低温 心肺转流 顺式阿曲库胺 罗库溴胺 Hypothermia Cardiopulmonary bypass Cisatracurium Rocuronium
  • 相关文献

参考文献5

  • 1孙瑗,王祥瑞.温度对于肌松药的影响[J].国外医学(麻醉学与复苏分册),2004,25(6):347-350. 被引量:7
  • 2Levin RL, Degrange MA, Bruno GF, et al. Methylene blue reduces mortality and morbidity in vasoplegie patients after cardiac surgery[J]. Ann Thorae Surg, 2004,77 (2) ; 496-499.
  • 3Cammu G, Hendrickx J. Dose requrrements of infusions of cisatracurium or rocurorium during hypothermic cardiopulmo- nary bypass[J]. Br J Anaesth, 2000,84 (5) : 587-590.
  • 4Gousaouzian NG, Standaert FG, Smith DC, et al. The influence of muscle temperature and forearm position on evoked elect romyography in the hand[J]. Br J Anaeth, 1994,72 (4) : 407- 410.
  • 5Carroll MT, Lowry D. Neuromuscular blocking effects and train-of-four of cisatracurium: comparison with other nondepolarising relaxants[J]. Br J Anaesth, 1998,53(12) : 1169-1173.

二级参考文献18

  • 1Beaufort AM, Wierda JM, Belopavlovic M, et al. The influence of hypothermia (surface cooling) on the time-course of action and on the pharmacokinetics of rocuronium in humans. Eur J Anaesthesiol Suppl, 1995, 11:95-106.
  • 2Aziz L,Ono K, Ohta Y. Effect of hypothermia on the in vitro potencies of neuromuscular blocking agents and on their antagonism by neostigmine.British Journal of Anaesthesia, 1994,73(5) :662-666.
  • 3England A J, Wu X, Richards KM, et al. The influence of cold on the recovery of three neuromuscular blocking agents in man. Anaesthesia,1996,51 (3) :236-240.
  • 4Smeulers NJ, Wierda JM, van den Broek L, et al. Effects of hypothermic cardiopulmonary bypass on the pharmacodynamics and pharmacokinetics of rocuronium. J Cardiothorac Vasc Anesth, 1995,9(6):700-705.
  • 5Ohnishi Y, Uchida O, Nakajima T,et al. Maintenance doses of vecuronium and pancuronium during hypothermic cardiopulmonary bypass. Masui,1993,42(7) :995-1001.
  • 6Asokumar B, Cheng D, Chung F, et al. Pharmacokinetics of doxacurium during normothermic and hypothermic cardiopulmonary bypass surgery.Can J Anaesth, 1998,45(6) :515-520.
  • 7Heier T, Clough D, Wright PM, et al. The influence of mild hypothermia on the pharmacokinetics and time course of action of neostigmine in anesthetized volunteers. Anesthesiology,2002,97( 1 ) :90-95.
  • 8Ceelen WP, Hesse U, de Hemptinne B, et al. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg,2001,88( 1 ): 152.
  • 9Kerner T, Deja M, Ahlers O, et al. Whole body hyperthermia: a secure procedure for patients with various malignancies.? Intensive Care Med,1999,25(9) :898-900.
  • 10Meyer RE, Page RL,Thrall DE, et al. Determination of continuous atracurium infusion rate in dogs undergoing whole-body hyperthermia. Cancer Research., 1986,46: 5599-5601.

共引文献6

同被引文献26

  • 1于丁宁,李铎.低体温的危害及治疗(文献综述)[J].国外医学(外科学分册),2004,31(5):258-261. 被引量:42
  • 2张沂,孙忠实,杨晋祥,金志强,钱毓洲.阿曲可林在心脏直视手术病人体内的药物动力学及药效学研究——体外循环前与体外循环中的比较[J].中国临床药理学杂志,1993,9(2):90-96. 被引量:3
  • 3李红梅,薛玉良.低温体外循环对罗库溴铵持续输注速度的影响[J].天津医药,2007,35(2):99-101. 被引量:2
  • 4Morris DL, Chambers HF, Morris MG, et al. Hemodynamic char- acteristics of patients with hypothermia due to occult infection and other causes [ J ]. Ann Intern Med, 1985,102 ( 2 ) :53 - 157.
  • 5Choi HA,Neeraj B,Stephan A. Hypothermia for acute brain injury - mechanisms and practical aspects [ J ]. Nat Rev Neurol, 2012,8 (4) :214 -222.
  • 6Koyo N, Madoka O, Ryuichi S, et al. Change in pharmacokinetics of model compounds with different elimination processes in rats during hypothermia [ J 1. Biol Pharm Bull, 2007,30 ( 9 ) : 1763 - 1767.
  • 7Marcel PH, Floris G, Antoine CG, et al. Effects of hypothermia on pharmacokinetics and pharmacodynamics [ J ]. Clin Pharmaco- kinet, 2010,49 ( 5 ) : 277 - 294.
  • 8Empey PE, Miller TM, Philbrick AI-I, et al. Mild hypothermia de- creases fentanyl and midazolam steady - state clearance in a rat model of cardiac arrest[J]. Crit Care Med,2012,40(4) :1221 - 1228.
  • 9Tortorici MA, Kochanek PM, Bies R, et al. Therapeutic hypother- mia-induced pharmacokinetic alterations on CYP2E1 chlorzoxazone-mediated metabolism in a cardiac arrest rat model [ J ]. Crit Care Med ,2006,34 ( 3 ) :785 - 791.
  • 10Caldwell JE, Heier T, Wright PM, et al. Temperature-dependent pharmacokinetics and pharmacodynamics of vecuronium [ J ]. Anesthesiology, 2000,92 ( 1 ) : 84 - 93.

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部